HX–37 / TXT–DT–01
LIFECARE LABS PRENATAL GENE THERAPY KIT
archived in
2038
Function
At-home somatic gene modulation for in utero health enhancement
This six-vial kit marked a turning point in prenatal care—when gene therapy entered the home and the womb became a site of proactive health optimization. Distributed by LifeCare Labs, the kit allowed expectant parents to administer nonheritable somatic gene therapies targeting fetal development systems such as neuroplasticity, innate immunity, metabolic resilience and disease predisposition.
Though constrained by early regulations to non-permanent edits, the availability of such therapies outside clinical settings was unprecedented. It shifted care upstream not only before symptoms, but before birth itself.
Marketed not as treatment but as a biological advantage, the kit promised a future where children could be buffered against inherited risk, enhanced for adaptability and primed for generational well-being. One formulation, for example, aimed to reduce cancer susceptibility linked to family history. Others optimized nutrient processing or cognitive elasticity in neurodiverse lineages.
curator’s note
THIS KIT EXTENDED HEALTH NOT JUST INTO THE HOME, BUT INTO THE UNBORN. IT REFRAMED PRENATAL CARE AS A DESIGN SPACE: A MOMENT WHEN PARENTS BECAME THE FIRST HEALTH ARCHITECTS OF SOMEONE NOT YET HERE.
Its rollout sparked fierce ethical debate over access, consent and the commercialization of gestation. But for many, it represented a new form of care, one that began before the first heartbeat.
Divergence from present
How radically this artifact departs from current healthcare norms, systems, or societal expectations.
Scale:
1 = Feels like today
10 = Requires a major paradigm shift
Mainstream adoption
How widely the artifact appears to have been adopted in its own speculative future.
Scale:
1 = Rare/fringe/experimental
10 = Wide/normalized
When people begin editing themselves—or their children—who defines what’s “better”?
This kit challenges every business shaping futures, identities or possibilities.
From HR policies to product design, ask yourself:
— Are you offering freedom—or writing unspoken rules?
— When improvement becomes expectation, where’s the room for difference?
What this demands of us
CURATORS
Heather Benoit is Director of Foresight and Innovation Design at Langrand, where she helps organizations imagine, design and make decisions in the present to realize more resilient futures. With a background in biomedical engineering and systems design, she combines analytical rigor with creative strategy.
Denise Worrell leads the Transformation and Experience Design practices at Langrand, using foresight and design to help organizations anticipate and navigate change. She also serves as an adjunct professor of foresight at the University of Houston and on the Design in Health Advisory Council at UT Austin.
INFO
This archive isn’t about forecasting the future—it’s about shaping it. Each artifact is a tool to spark conversation, challenge assumptions and stretch the imagination around what feels possible. Some feel likely. Others push the edge.
Designed for teams navigating complexity, these provocations help surface blind spots, shift perspectives and drive more intentional decision-making. They’re meant to question dominant narratives, fuel collective imagination and co-create systems that are not just improved, but radically redesigned with people at the center.
These artifacts aren’t about certainty—they’re starting points, an invitation to imagine boldly and lead like the future depends on it. Because foresight isn’t about guessing what’s next, it’s about choosing the future you want to build and beginning that work now.